Fusen Pharmaceutical Company Limited

HKEX:1652.HK

1 (HKD) • At close September 11, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 114.586114.586168.219168.219163.073163.07382.80682.80685.72685.726107.106107.106119.676119.676123.751123.751105.476105.47698.21998.21995.07795.077135.954135.954140.383115.832115.832114.971110.497110.497110.49792.15992.15992.15992.159
Cost of Revenue 54.39254.39278.6678.6690.42990.42942.93942.93939.27639.27647.9947.9953.05853.05857.33657.33652.64252.64244.80844.80843.84643.84661.52661.52663.06151.9651.9657.03554.9554.9554.9548.83948.83948.83948.839
Gross Profit 60.19460.19489.55989.55972.64472.64439.86739.86746.45146.45159.11659.11666.61866.61866.41666.41652.83452.83453.41153.41151.23151.23174.42874.42877.32263.87263.87257.93655.54755.54755.54743.31943.31943.31943.319
Gross Profit Ratio 0.5250.5250.5320.5320.4450.4450.4810.4810.5420.5420.5520.5520.5570.5570.5370.5370.5010.5010.5440.5440.5390.5390.5470.5470.5510.5510.5510.5040.5030.5030.5030.470.470.470.47
Reseach & Development Expenses 28.47728.47712.01412.0142.6862.6865.0035.0032.2852.2853.0353.0359.9789.9783.6613.6612.5562.5563.2483.2485.6115.611001.281000.5130000000
General & Administrative Expenses 7.5587.55829.89229.89213.42113.42113.95213.95216.85316.85315.76515.76515.55815.55823.87923.87916.40716.40712.95812.95810.38610.38614.26714.26710.74511.1511.1518.51210.06910.06910.0696.516.516.516.51
Selling & Marketing Expenses 30.22530.22539.54639.54637.06437.06422.29722.29720.01620.01625.45725.45725.49325.49328.21128.21127.95727.95728.44628.44616.76516.76528.02928.02932.95321.05121.05119.61118.55218.55218.55215.90915.90915.90915.909
SG&A 37.78337.78369.43769.43750.48450.48436.24936.24936.86936.86941.22241.22241.05141.05152.0952.0944.36444.36441.40341.40327.15127.15142.29542.29543.69832.20132.20138.12328.62128.62128.62122.41922.41922.41922.419
Other Expenses 000000000000000000-1.414-1.414-1.4140-2.915-2.915-2.915-1.377-1.377-1.377-2.538-2.538-2.538-0.659-0.659-0.659-0.659
Operating Expenses 82.55582.55575.84375.84381.91181.91140.89140.89158.95658.95631.87231.87246.41246.41243.41643.41633.49933.49938.07538.07520.38820.38836.76636.76643.16330.97630.97635.25326.08426.08426.08421.7621.7621.7621.76
Operating Income -8.675-8.67519.40119.40119.11719.1173.5893.5898.0578.05724.90224.90225.44525.44515.42315.4237.3817.38116.25216.25224.87724.87737.41937.41934.15932.79632.79622.58538.31238.31238.31224.62524.62524.62524.625
Operating Income Ratio -0.076-0.0760.1150.1150.1170.1170.0430.0430.0940.0940.2320.2320.2130.2130.1250.1250.070.070.1650.1650.2620.2620.2750.2750.2430.2830.2830.1960.3470.3470.3470.2670.2670.2670.267
Total Other Income Expenses Net -17.498-17.498-7.953-7.953-30.957-30.957-7.246-7.246-21.56-21.560.4970.497-7.181-7.1815.5165.51610.7410.74-2.465-2.4653.8333.833-4.222-4.222-5.203-1.236-1.236-4.339-9.62-9.62-9.62-10.308-10.308-10.308-10.308
Income Before Tax -26.172-26.17211.44811.448-11.84-11.84-3.657-3.657-13.503-13.50325.39925.39918.26418.26420.93920.93918.1218.1213.78713.78728.7128.7133.19733.19728.95631.56131.56118.24628.69228.69228.69214.31714.31714.31714.317
Income Before Tax Ratio -0.228-0.2280.0680.068-0.073-0.073-0.044-0.044-0.158-0.1580.2370.2370.1530.1530.1690.1690.1720.1720.140.140.3020.3020.2440.2440.2060.2720.2720.1590.260.260.260.1550.1550.1550.155
Income Tax Expense 0.1990.1993.2253.2251.9491.9490.1180.1180.0950.0953.4943.4943.6453.6454.2244.2243.8573.8571.9211.9214.54.56.4536.4534.755.3725.3723.7554.6434.6434.6432.8082.8082.8082.808
Net Income -26.367-26.3678.2288.228-13.784-13.784-3.519-3.519-13.637-13.63721.9621.9617.59917.59917.46717.46714.8914.8911.82811.82824.19224.19226.74926.74924.30426.05226.05213.9224.0524.0524.0511.50911.50911.50911.509
Net Income Ratio -0.23-0.230.0490.049-0.085-0.085-0.042-0.042-0.159-0.1590.2050.2050.1470.1470.1410.1410.1410.1410.120.120.2540.2540.1970.1970.1730.2250.2250.1210.2180.2180.2180.1250.1250.1250.125
EPS -0.035-0.0350.010.01-0.02-0.02-0.005-0.005-0.02-0.020.0290.0290.0230.0230.020.020.0190.0190.0150.0150.0310.0310.0450.0450.030.0430.0430.0230.030.030.030.0140.0140.0140.014
EPS Diluted -0.035-0.0350.0110.011-0.018-0.018-0.005-0.005-0.018-0.0180.0280.0280.0230.0230.0220.0220.0190.0190.0150.0150.0310.0310.0450.0450.030.0430.0430.0230.030.030.030.0140.0140.0140.014
EBITDA -1.115-1.11525.89225.89226.54526.5459.629.6212.90512.90528.76928.76929.52929.52919.5419.5411.42711.42720.27320.27328.8728.8741.4841.4838.42137.05537.05526.54242.12442.12442.12428.39128.39128.39128.391
EBITDA Ratio -0.01-0.010.1540.1540.1630.1630.1160.1160.1510.1510.2690.2690.2470.2470.1580.1580.1080.1080.2060.2060.3040.3040.3050.3050.2740.320.320.2310.3810.3810.3810.3080.3080.3080.308